Debt Financing - Lys Therapeutics
Investment Firm
Overview
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
Announced Date
Nov 14, 2022
Funding Type
Debt Financing
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Lys Therapeutics raised $2579958 on 2022-11-14 in Debt Financing
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 14, 2022 |  Debt Financing - Lys Therapeutics | 1 | - | 2.6M |
| Mar 15, 2023 | Grant - Lys Therapeutics | 1 | - | 600.0K |
| Mar 31, 2021 | Non Equity Assistance - Lys Therapeutics | 2 | - | undefined |
| May 15, 2023 | Non Equity Assistance - Lys Therapeutics | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.